A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 12 Weeks Treatment With Vildagliptin (50mg qd, 50mg Bid, 100mg qd) to Placebo in Patients With Type 2 Diabetes

Name: A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 12 Weeks Treatment With Vildagliptin (50mg qd, 50mg Bid, 100mg qd) to Placebo in Patients With Type 2 Diabetes
Creator: Vivli
Published: 2025-12-16 15:15:43
License: 暂无描述

DataCite Commons2025-12-16 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012374/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This study is not being conducted in the United States. Vildagliptin is an oral antidiabetic agent. This 12-week clinical study is to evaluate the effect of vildagliptin 50mg qd, 50mg bid or 100mg qd compared to placebo in patients with type 2 diabetes.

提供机构：

Vivli

创建时间：

2025-12-16